Added to YB: 2023-01-30
Pitch date: 2023-01-30
HZNP [bullish]
Horizon Therapeutics Public Limited Company
+5.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases.
Market Cap
$26.6B
Pitch Price
$110.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
39.41
P/E
61.85
EV/Sales
7.37
Sector
Biotechnology
Category
N/A
Show full summary:
HORIZON THERAPEUTICS PUB LTD HZNP
A summary for this pitch has not been created yet.
Read full article (0 min)